Vivos Therapeutics Inc (VVOS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -230.107 | -149.2 | -37.264 | -68.754 | -100.593 | -111.108 |
Return on Equity (%) | -391.092 | -1247.771 | -87.677 | -95.572 | -157.185 | -521.22 |
Return on Invested Capital (%) | -278.238 | -641.225 | -171.819 | -92.447 | -168.605 | -763.452 |
Operating Margin (%) | -219.831 | -93.18 | -91.535 | -120.071 | -148.808 | -98.42 |
Net Profit Margin (%) | -248.919 | -103.169 | -46.885 | -120.154 | -148.808 | -98.42 |
Book Value Per Share | 0.051 | -0.401 | 0.768 | 0.971 | 0.072 | -2.383 |
Earnings Per Share | -0.782 | -0.945 | -0.336 | -0.882 | -1.036 | -11.348 |
Cash Per Share | 0.104 | 0.038 | 1 | 1.044 | 0.153 | 1.373 |
Working Capital Per Share | -0.012 | -0.571 | 0.69 | 0.861 | -0.06 | -4.033 |
Operating Profit Per Share | 0.225 | 0.696 | 0.572 | 0.548 | 0.435 | 6.91 |
EBIT Per Share | -0.699 | -0.864 | -0.662 | -0.882 | -1.036 | -11.348 |
EBITDA Per Share | -0.699 | -0.864 | -0.662 | -0.882 | -1.036 | -11.348 |
Free Cash Flow Per Share | -0.729 | -0.991 | -0.369 | -0.809 | -1.025 | -11.154 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 12,07M | 12,44M | 18,21M | 23,01M | 23,01M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 23,01M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -44.153 | N/A | N/A | N/A | -110.061 | N/A | N/A |
Net Profit Margin (%) | N/A | -44.153 | N/A | N/A | N/A | -110.061 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 21,47M |
Ratio cours/bénéfice | -1,53 |
Ratio prix/ventes | 1,5 |
Ratio prix/liquidités | 12,63 |
Ratio prix/valeur comptable | 50,47 |
Rendement de dividende | - |
Actions en circulation | 4,84M |
Volume moyen (1 semaine) | 230,48k |
Volume moyen (1 mois) | 236,64k |
Variation sur 52 semaines | -66,43% |
Plus haut sur 52 semaines | 12,75 |
Plus bas sur 52 semaines | 1,91 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales